188 related articles for article (PubMed ID: 8181145)
1. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
Ito H; Hiroe M; Hirata Y; Fujisaki H; Adachi S; Akimoto H; Ohta Y; Marumo F
Circulation; 1994 May; 89(5):2198-203. PubMed ID: 8181145
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-3 induces hypertrophy of cardiomyocytes by the endogenous endothelin-1-mediated mechanism.
Tamamori M; Ito H; Adachi S; Akimoto H; Marumo F; Hiroe M
J Clin Invest; 1996 Jan; 97(2):366-72. PubMed ID: 8567956
[TBL] [Abstract][Full Text] [Related]
4. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
Bianciotti LG; de Bold AJ
Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
7. Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
Moser L; Faulhaber J; Wiesner RJ; Ehmke H
Am J Physiol Regul Integr Comp Physiol; 2002 May; 282(5):R1389-94. PubMed ID: 11959681
[TBL] [Abstract][Full Text] [Related]
8. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.
Massart PE; Donckier J; Kyselovic J; Godfraind T; Heyndrickx GR; Wibo M
Hypertension; 1999 Dec; 34(6):1197-201. PubMed ID: 10601118
[TBL] [Abstract][Full Text] [Related]
10. Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism.
Ito H; Adachi S; Tamamori M; Fujisaki H; Tanaka M; Lin M; Akimoto H; Marumo F; Hiroe M
J Mol Cell Cardiol; 1996 Jun; 28(6):1271-7. PubMed ID: 8782068
[TBL] [Abstract][Full Text] [Related]
11. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload.
Yorikane R; Sakai S; Miyauchi T; Sakurai T; Sugishita Y; Goto K
FEBS Lett; 1993 Oct; 332(1-2):31-4. PubMed ID: 8405444
[TBL] [Abstract][Full Text] [Related]
12. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
Ito H; Hirata Y; Adachi S; Tanaka M; Tsujino M; Koike A; Nogami A; Murumo F; Hiroe M
J Clin Invest; 1993 Jul; 92(1):398-403. PubMed ID: 8326007
[TBL] [Abstract][Full Text] [Related]
14. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
Sakai S; Miyauchi T; Irukayama-Tomobe Y; Ogata T; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():16S-20S. PubMed ID: 12193046
[TBL] [Abstract][Full Text] [Related]
16. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y
Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844
[TBL] [Abstract][Full Text] [Related]
17. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats.
Garjani A; Wainwright CL; Zeitlin IJ; Wilson C; Slee SJ
J Cardiovasc Pharmacol; 1995 Apr; 25(4):634-42. PubMed ID: 7596133
[TBL] [Abstract][Full Text] [Related]
18. Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: an in situ hybridization histochemical study.
Young RL; Gundlach AL; Louis WJ
Cardiovasc Res; 1998 Jan; 37(1):187-201. PubMed ID: 9539873
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of endothelin-1 in cardiac hypertrophy.
Yorikane R; Sakai S; Miyauchi T; Sakurai T; Goto K
Arzneimittelforschung; 1994 Mar; 44(3A):412-5. PubMed ID: 8185715
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy.
Arai M; Yoguchi A; Iso T; Takahashi T; Imai S; Murata K; Suzuki T
Am J Physiol; 1995 May; 268(5 Pt 2):H2084-91. PubMed ID: 7771559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
